Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  Bladder Cancer

  Free Subscription


Articles published in Cancer Res

Retrieve available abstracts of 18 articles:
HTML format



Single Articles


    May 2022
  1. NI Z, Sun P, Zheng J, Wu M, et al
    JNK Signaling Promotes Bladder Cancer Immune Escape by Regulating METTL3-Mediated m6A Modification of PD-L1 mRNA.
    Cancer Res. 2022;82:1789-1802.
    PubMed     Abstract available


    April 2022
  2. AN M, Zheng H, Huang J, Lin Y, et al
    Aberrant Nuclear Export of circNCOR1 Underlies SMAD7-Mediated Lymph Node Metastasis of Bladder Cancer.
    Cancer Res. 2022 Apr 8. pii: 694333. doi: 10.1158/0008-5472.CAN-21-4349.
    PubMed     Abstract available


    January 2022
  3. WANG Y, Zhang Y, Li PC, Guo J, et al
    Development of novel aptamer-based targeted chemotherapy for bladder cancer.
    Cancer Res. 2022 Jan 21. pii: 0008-5472.CAN-21-2691.
    PubMed     Abstract available


  4. BELLAT V, Michel AO, Thomas C, Stokol T, et al
    A urinary drug-disposing approach as an alternative to intravesical chemotherapy for treating non-muscle invasive bladder cancer.
    Cancer Res. 2022 Jan 17. pii: 0008-5472.CAN-21-2897.
    PubMed     Abstract available


    December 2021
  5. XIA Y, Wang X, Liu Y, Shapiro E, et al
    PKM2 is essential for bladder cancer growth and maintenance.
    Cancer Res. 2021 Dec 13. pii: 0008-5472.CAN-21-0403.
    PubMed     Abstract available


    November 2021
  6. JING W, Wang G, Cui Z, Xiong G, et al
    FGFR3 Destabilizes PD-L1 Via NEDD4 to Control T Cell-Mediated Bladder Cancer Immune Surveillance.
    Cancer Res. 2021 Nov 9. pii: 0008-5472.CAN-21-2362.
    PubMed     Abstract available


    October 2021
  7. WEI W, Sun J, Zhang H, Xiao X, et al
    Circ0008399 interaction with WTAP promotes assembly and activity of the m6A methyltransferase complex and promotes cisplatin resistance in bladder cancer.
    Cancer Res. 2021 Oct 26. pii: 0008-5472.CAN-21-1518.
    PubMed     Abstract available


    September 2021
  8. YANG L, Sun J, Li M, Long Y, et al
    Oxidized low-density lipoprotein links hypercholesterolemia and bladder cancer aggressiveness by promoting cancer stemness.
    Cancer Res. 2021 Sep 3. pii: 0008-5472.CAN-21-0646.
    PubMed     Abstract available


  9. PARK S, Rong L, Owczarek TB, Di Bernardo M, et al
    Novel mouse models of bladder cancer identify a prognostic signature associated with risk of disease progression.
    Cancer Res. 2021 Sep 1. pii: 0008-5472.CAN-21-1254.
    PubMed     Abstract available


    April 2021
  10. FUHRMAN BJ, Moore SC, Byrne C, Makhoul I, et al
    Association of the Age at Menarche with Site-Specific Cancer Risks in Pooled Data from Nine Cohorts.
    Cancer Res. 2021;81:2246-2255.
    PubMed     Abstract available


    March 2021
  11. WULLWEBER A, Strick R, Lange F, Sikic D, et al
    Bladder Tumor Subtype Commitment Occurs in Carcinoma In Situ Driven by Key Signaling Pathways Including ECM Remodeling.
    Cancer Res. 2021;81:1552-1566.
    PubMed     Abstract available


  12. SOTTNIK JL, Vanderlinden LA, Joshi M, Chauca-Diaz A, et al
    Androgen Receptor Regulates CD44 Expression in Bladder Cancer.
    Cancer Res. 2021 Mar 9. pii: 0008-5472.CAN-20-3095.
    PubMed     Abstract available


    November 2020
  13. DOMINGUEZ GUTIERREZ PR, Kwenda EP, Donelan W, O'Malley P, et al
    Hyal2 expression in tumor-associated myeloid cells mediates cancer-related inflammation in bladder cancer.
    Cancer Res. 2020 Nov 25. pii: 0008-5472.CAN-20-1144.
    PubMed     Abstract available


    August 2020
  14. BELLMUNT J, Kim J, Reardon B, Perera-Bel J, et al
    Genomic predictors of good outcome, recurrence or progression in High grade T1 non-muscle invasive bladder cancer.
    Cancer Res. 2020 Aug 31. pii: 0008-5472.CAN-20-0977.
    PubMed     Abstract available


    July 2020
  15. KIKUCHI H, Maishi N, Annan DA, Alam MT, et al
    Chemotherapy-Induced IL8 Upregulates MDR1/ABCB1 in Tumor Blood Vessels and Results in Unfavorable Outcome.
    Cancer Res. 2020;80:2996-3008.
    PubMed     Abstract available


  16. BUI NHB, Napoli M, Davis AJ, Abbas HA, et al
    Spatiotemporal Regulation of DeltaNp63 by TGFbeta-Regulated miRNAs Is Essential for Cancer Metastasis.
    Cancer Res. 2020;80:2833-2847.
    PubMed     Abstract available


    February 2020
  17. HU B, Wang Z, Zeng H, Qi Y, et al
    Blockade of DC-SIGN+ tumor-associated macrophages reactivates anti-tumor immunity and improves immunotherapy in muscle-invasive bladder cancer.
    Cancer Res. 2020 Feb 14. pii: 0008-5472.CAN-19-2254.
    PubMed     Abstract available


    January 2020
  18. LOH XY, Sun QY, Ding LW, Mayakonda A, et al
    RNA-Binding Protein ZFP36L1 Suppresses Hypoxia and Cell-Cycle Signaling.
    Cancer Res. 2020;80:219-233.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Bladder Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: